Clinical and Genomic Risk in Adjuvant Therapy for...

Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer

Abstract

To the Editor: Sparano et al. (June 20 issue)1 report prognostic and predictive implications by integrating clinical-risk stratification with a 21-gene assay to guide adjuvant therapy in patients w...

Authors

Schvartsman G; Kaliks RA

Journal

The New England Journal of Medicine, Vol. 381, No. 13, pp. 1289–1291

Publisher

Massachusetts Medical Society

Publication Date

September 26, 2019

DOI

10.1056/nejmc1909693

ISSN

0028-4793

Associated Experts

Holger Schunemann

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels

Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team